Cognitive decline in older persons initiating anticholinergic medications.
about
Mirabegron in overactive bladder patients: efficacy review and update on drug safetyAnticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic reviewClinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units.Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older AdultsSystematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease.Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder.Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.Nurse Education to Reduce Harmful Medication Use in Assisted Living Facilities: Effects of a Randomized Controlled Trial on Falls and Cognition.Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.In geriatric patients, delirium symptoms are related to the anticholinergic burden.Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults.Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
P2860
Q28072230-7A87B48A-F34D-4D31-8339-2E2715AF7079Q28085414-7FE6B702-BA8A-418D-8356-357BFB2A1804Q31155412-B6900898-28C0-46FC-BF31-41289F1ADAD3Q35797865-9EABCCD1-44B4-4ED6-A63B-1C047F63BCF6Q37268405-241873FA-4C46-4CDB-9759-41B64CF4F3E4Q38344080-B34A3DF8-308A-4757-BB31-33C1F2FF9C00Q38583153-155052DB-0354-40CF-96D0-AF4A8BC82A1DQ38802441-35CB3552-2653-4D6D-B8B1-A287884007E1Q39379518-E790DABF-4525-46AC-8852-86C917430AC2Q40456134-4F4856CF-5EEE-4EDE-B69B-536398E0FCB4Q41214474-BA288641-4841-4DF4-ABDB-766B6DC28BCEQ41568753-056968F5-AE6B-4C74-BD44-C3A7C2A9019CQ41754885-079B238A-2043-41C8-BF7E-356D28EB39BBQ42655639-72762DA5-0825-4063-BE3F-8651C82EB114Q47741746-52DA8227-4B39-4CEE-A252-05A1E2AB6A58
P2860
Cognitive decline in older persons initiating anticholinergic medications.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cognitive decline in older persons initiating anticholinergic medications.
@ast
Cognitive decline in older persons initiating anticholinergic medications.
@en
Cognitive decline in older persons initiating anticholinergic medications.
@nl
type
label
Cognitive decline in older persons initiating anticholinergic medications.
@ast
Cognitive decline in older persons initiating anticholinergic medications.
@en
Cognitive decline in older persons initiating anticholinergic medications.
@nl
prefLabel
Cognitive decline in older persons initiating anticholinergic medications.
@ast
Cognitive decline in older persons initiating anticholinergic medications.
@en
Cognitive decline in older persons initiating anticholinergic medications.
@nl
P2093
P2860
P1433
P1476
Cognitive decline in older persons initiating anticholinergic medications.
@en
P2093
Alicia L Janos
Jack W Tsao
Julia E Kline
Kenneth M Heilman
Raj C Shah
Robert S Wilson
P2860
P304
P356
10.1371/JOURNAL.PONE.0064111
P407
P577
2013-05-31T00:00:00Z